1.8800
+0.0300
+(1.62%)
At close: 12:06:25 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 2 | 6 | 6 |
| Avg. Estimate | 25k | 50k | 125.33k | 2.6M |
| Low Estimate | -- | -- | 100k | -- |
| High Estimate | 100k | 100k | 200k | 15.2M |
| Year Ago Sales | 102.65k | -- | 832.01k | 125.33k |
| Sales Growth (year/est) | -75.65% | 0.00% | -84.94% | 1,974.52% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GBM.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 1/13/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 11/18/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/18/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 11/15/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 8/12/2024 |
Related Tickers
6XP.SG Xspray Pharma AB (publ)
2.7700
-0.36%
6XY.F HBM Holdings Limited
0.6450
+4.88%
CRO.BE Open Orphan PLC
0.1990
0.00%
8JD.F Valbiotis SA
1.2760
+1.11%
I5X.F Precigen, Inc.
1.6450
+4.58%
HPHA.F Heidelberg Pharma AG
2.6300
-5.73%
CRO.F hVIVO plc
0.1740
+4.82%
OPORF hVIVO plc
0.2400
-31.43%
8C5.F Coherus BioSciences, Inc.
1.0195
-0.44%
2LB.F Iovance Biotherapeutics, Inc.
3.8710
-2.32%